EA200000112A1 - Новая композиция - Google Patents
Новая композицияInfo
- Publication number
- EA200000112A1 EA200000112A1 EA200000112A EA200000112A EA200000112A1 EA 200000112 A1 EA200000112 A1 EA 200000112A1 EA 200000112 A EA200000112 A EA 200000112A EA 200000112 A EA200000112 A EA 200000112A EA 200000112 A1 EA200000112 A1 EA 200000112A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- new composition
- ssri
- blocker
- published
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
PCT/EP1998/004971 WO1999002142A2 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200000112A1 true EA200000112A1 (ru) | 2000-10-30 |
Family
ID=10815744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000112A EA200000112A1 (ru) | 1997-07-11 | 1998-07-07 | Новая композиция |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0996466A2 (xx) |
JP (1) | JP2002508003A (xx) |
KR (1) | KR20010021644A (xx) |
CN (1) | CN1262627A (xx) |
AP (1) | AP2000001728A0 (xx) |
AR (1) | AR016128A1 (xx) |
AU (1) | AU9340198A (xx) |
BG (1) | BG104119A (xx) |
BR (1) | BR9810996A (xx) |
CA (1) | CA2295822A1 (xx) |
CO (1) | CO4950552A1 (xx) |
DZ (1) | DZ2556A1 (xx) |
EA (1) | EA200000112A1 (xx) |
GB (1) | GB9714675D0 (xx) |
HU (1) | HUP0003074A3 (xx) |
ID (1) | ID24191A (xx) |
IL (1) | IL133869A0 (xx) |
MA (1) | MA24604A1 (xx) |
NO (1) | NO20000107L (xx) |
OA (1) | OA11276A (xx) |
PE (1) | PE99699A1 (xx) |
PL (1) | PL338017A1 (xx) |
SK (1) | SK72000A3 (xx) |
TR (1) | TR200000074T2 (xx) |
WO (1) | WO1999002142A2 (xx) |
ZA (1) | ZA986138B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE457169T1 (de) | 1998-10-15 | 2010-02-15 | Imp Innovations Ltd | Verbindungen für die behandlung von gewichtsverlust |
IL142896A0 (en) | 1998-11-02 | 2002-04-21 | Elan Corp Plc | Multiparticulate modified release composition |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
RU2230556C2 (ru) | 1999-10-29 | 2004-06-20 | Эро-Селтик, С.А. | Препаративные формы гидрокодона с контролируемым высвобождением |
GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
AU2002227383B2 (en) | 2000-10-30 | 2004-07-08 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
EP1793818A2 (en) * | 2004-09-17 | 2007-06-13 | Neurocure Ltd. | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
AU6776196A (en) * | 1995-08-16 | 1997-03-12 | Eli Lilly And Company | Potentiation of serotonin response |
EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20000107D0 (no) | 2000-01-10 |
BR9810996A (pt) | 2000-08-08 |
DZ2556A1 (fr) | 2003-02-15 |
PL338017A1 (en) | 2000-09-25 |
CO4950552A1 (es) | 2000-09-01 |
ID24191A (id) | 2000-07-13 |
AP2000001728A0 (en) | 2000-03-31 |
HUP0003074A3 (en) | 2001-12-28 |
JP2002508003A (ja) | 2002-03-12 |
CN1262627A (zh) | 2000-08-09 |
SK72000A3 (en) | 2000-12-11 |
GB9714675D0 (en) | 1997-09-17 |
AR016128A1 (es) | 2001-06-20 |
WO1999002142A2 (en) | 1999-01-21 |
TR200000074T2 (tr) | 2000-05-22 |
BG104119A (en) | 2000-12-29 |
WO1999002142A3 (en) | 1999-04-15 |
PE99699A1 (es) | 1999-12-21 |
CA2295822A1 (en) | 1999-01-21 |
MA24604A1 (fr) | 1999-04-01 |
EP0996466A2 (en) | 2000-05-03 |
OA11276A (en) | 2003-07-31 |
IL133869A0 (en) | 2001-04-30 |
HUP0003074A2 (hu) | 2001-01-29 |
AU9340198A (en) | 1999-02-08 |
KR20010021644A (ko) | 2001-03-15 |
NO20000107L (no) | 2000-01-10 |
ZA986138B (en) | 2000-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9912975A (pt) | Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso | |
RS50485B (sr) | Terapeutske kombinacije koje sadrže amplodipin i atorvastatin | |
EA200100773A1 (ru) | Замещенные 1-гетероциклические диариламины | |
ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
TR199800077T1 (xx) | Kontroll� ��z�len paroksetin terkipleri. | |
BR9710372B1 (pt) | composto, e, composiÇço farmacÊutica. | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
BR9808491A (pt) | Compostos calcilìticos | |
SE9704546D0 (sv) | Novel compounds | |
EA200001039A1 (ru) | Кальцилитические соединения | |
AR016981A2 (es) | Polipeptidos sinteticos | |
SE9802937D0 (sv) | Novel compounds | |
ES2181168T3 (es) | Mezclas solidas a base de sulfonilureas y adyuvantes. | |
EA200000112A1 (ru) | Новая композиция | |
TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
ES2170396T3 (es) | Composiciones farmaceuticas a base de diclofenac. | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
EA199800753A1 (ru) | Бензотиофены, составы их содержащие и способы с их использованием | |
PT929299E (pt) | 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos | |
ES2174150T3 (es) | Procedimiento para la obtencion de 4-hidroxianilinas. | |
AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
NO985079L (no) | Eksplosiv formulering | |
ES2158441T3 (es) | Arilheterociclos con actividad herbicida. | |
ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge | |
ES2116946B1 (es) | Composicion para la obtencion de un aguardiente. |